Industry News
New Kidney Cancer Vaccine Shows Promise
Aug 06, 2012
In the current edition of Nature Medicine, researchers at the University of Tübingen and immatics biotechnologies GmbH report on the results of two clinical trials testing the kidney-cancer vaccine IMA901. The vaccine, which is composed of ten synthetic tumor-associated peptides (TUMAPs), is used to treat individuals suffering from kidney cancer... Read More
Risk Of Brain Tumors May Be Lower In Those With Allergies
Aug 06, 2012
New research adds to the growing body of evidence suggesting that there's a link between allergies and reduced risk of a serious type of cancer that starts in the brain. This study suggests the reduced risk is stronger among women than men, although men with certain allergy profiles also have a lower tumor risk... Read More
Pluristem's PLX Cells Show Efficacy In Treating Lung Disease
Aug 06, 2012
Statistically significant animal model results indicate PLX cells could improve the lives of people worldwide with interstitial lung disease in a four billion dollar market Pluristem Therapeutics, Inc... Read More
Afinitor Approved In Europe For Advanced Breast Cancer
Aug 06, 2012
E.U. approval has been granted to Novartis drug Afinitor® (everolimus) after successful completion of the Phase III BOLERO-2 (Breast cancer trials of OraL EveROlimus-2) trial... Read More
Afinitor Approved In Europe For Advanced Breast Cancer
Aug 06, 2012
E.U. approval has been granted to Novartis drug Afinitor® (everolimus) after successful completion of the Phase III BOLERO-2 (Breast cancer trials of OraL EveROlimus-2) trial... Read More
Plant-Based Compound Slows Breast Cancer In A Mouse Model
Aug 06, 2012
The natural plant compound phenethyl isothiocyanate (PEITC) hinders the development of mammary tumors in a mouse model with similarities to human breast cancer progression, according to a study published August 2 in the Journal of the National Cancer Institute. Edible plants are gaining ground as chemopreventative agents... Read More
The Unique Role Of Heat-Shock Factor In Supporting Highly Malignant Cancers
Aug 06, 2012
Whitehead Institute researchers have found that increased expression of a specific set of genes is strongly associated with metastasis and death in patients with breast, colon, and lung cancers... Read More
The Unique Role Of Heat-Shock Factor In Supporting Highly Malignant Cancers
Aug 06, 2012
Whitehead Institute researchers have found that increased expression of a specific set of genes is strongly associated with metastasis and death in patients with breast, colon, and lung cancers... Read More
Critical Tumor Suppressor Identified For Cancer
Aug 05, 2012
Scientists from the Florida campus of The Scripps Research Institute have identified a protein that impairs the development and maintenance of lymphoma (cancer of the lymph nodes), but is repressed during the initial stages of the disease, allowing for rapid tumor growth... Read More
Critical Tumor Suppressor Identified For Cancer
Aug 05, 2012
Scientists from the Florida campus of The Scripps Research Institute have identified a protein that impairs the development and maintenance of lymphoma (cancer of the lymph nodes), but is repressed during the initial stages of the disease, allowing for rapid tumor growth... Read More
Previous Page Next Page